                         SEQUENCE LISTING

<110>  The University of PIttsburgh - of the Commonwealth System 
       of Higher Education
 
<120>  USe of survivin antagonists in merkel cell polyomavirus-related 
       disease

<130>  6527-130790

<150>  US 61/615,546
<151>  2012-03-26

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  58
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  MCV T antigen shRNA

<400>  1
ccggccgcat ctctacattc aagaactcga gttcttgaat gtagagatgc ggtttttg         58


<210>  2
<211>  58
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  MCV T antigen shRNA

<400>  2
ccggcctttc tgtcaagaag cagttctcga gaactgcttc ttgacagaaa ggtttttg         58


<210>  3
<211>  17
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  forward survivin primer

<400>  3
ctgcctggca gcccttt                                                      17


<210>  4
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  reverse survivin primer

<400>  4
cctccaagaa gggccagttc                                                   20


<210>  5
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  forward beta-actin primer

<400>  5
cactggctcg tgtgacaagg                                                   20


<210>  6
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  reverse beta-actin primer

<400>  6
cagacctact gtgcgcctac ttaa                                              24


